[Plasmapheresis in the treatment of cytostatic disease in patients with lymphogranulomatosis].
Belkov
S A
SA
Andriukhin
V I
VI
Korsakov
V B
VB
Pugachev
V F
VF
Riazantsev
E A
EA
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000528:radiation effects*; D008231:Lymphopenia / Q000209:etiology / Q000628:therapy*; D008297:Male; D010956:Plasmapheresis; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011832:Radiation Injuries / Q000150:complications*; D011882:Radiotherapy, High-Energy / Q000009:adverse effects*; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone
Plazmaferez v lechenii tsitostaticheskoĭ bolezni u bol'nykh limfogranulomatozom.